Loading: 100%
SURMODICS INC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 219 (as per FY 2016)no data available
Sector Medical Diagnostics & Research, HealthcareMedical Diagnostics & Research, Healthcareno data available
Ticker SRDXno data available
Financial year endsFY ends End of Septemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1721,024,528,031,535,0
datesClosing price (adj.)
13.10.201731.45
11.10.201731.10
04.10.201731.95
27.09.201731.10
20.09.201730.55
13.09.201727.25
06.09.201727.15
30.08.201725.70
23.08.201725.55
16.08.201725.40
09.08.201724.90
02.08.201725.70
26.07.201727.65
19.07.201728.00
12.07.201727.20
05.07.201727.90
27.06.201727.55
20.06.201724.90
13.06.201725.00
06.06.201724.95
30.05.201724.25
23.05.201723.05
16.05.201723.10
09.05.201722.95
02.05.201722.73
25.04.201724.15
18.04.201724.05
11.04.201723.25
04.04.201723.53
28.03.201723.40
21.03.201723.70
14.03.201724.05
07.03.201724.30
28.02.201724.75
21.02.201725.20
14.02.201723.95
07.02.201724.00
31.01.201724.20
24.01.201724.55
17.01.201724.80
10.01.201725.35
03.01.201725.90
27.12.201625.90
19.12.201625.20
12.12.201625.40
05.12.201624.00
28.11.201624.90
21.11.201625.60
14.11.201627.90
07.11.201625.25
31.10.201624.90
24.10.201627.75
17.10.201628.50
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
31.45n/a
Market Capitalisation
in million USD
415n/a
Enterprise Value
in million USD
368n/a
Common Shares Outstanding
as per Sep 30, 2016
13,208,443n/a
Preferred Shares Outstanding
as per Sep 30, 2016
n/a
Average Basic Shares Outstanding
TTM
12,998,000n/a
Average Diluted Shares Outstanding
TTM
13,219,000n/a
Index Membership
n/a
Business Summary
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 47n/a
Receivables 7n/a
Total Current Assets 59n/a
PP&E 20n/a
Total Assets 133n/a
Accounts Payable 2n/a
Current Debt 0n/a
Total Current Liabilities 10n/a
Long-Term Debt 0n/a
Total Liabilities 26n/a
Total Equity 107n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow 0n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 0n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share 8.22n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value 3.83n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value 0.26n/a
Other Ratios
Current Ratio 577.8%n/a
Liabilities to Equity Ratio 24.4%n/a
Debt to Assets Ratio 0.0%n/a
Profit & Loss StatementP&L data quality: 0% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
122
54
53
52
56
57
62
71
Sales & Services Revenue
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
Cost of revenue
-8
-7
-7
-7
-8
-8
-9
-11
Cost of Goods & Services
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
Gross Profit
114
48
46
45
48
49
53
60
Other Operating Income
0
0
0
0
0
0
0
0
Operating Expenses
-38
-31
-29
-28
-29
-30
-31
-36
Selling, General & Administrative
-17
-13
-15
-14
-14
-15
-15
-18
Selling & Marketing
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
Research & Development
-21
-19
-14
-14
-15
-16
-16
-18
Depreciation & Amortization
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
Operating Income (Loss)
76
16
17
16
19
19
22
24
Non-Operating Income (Loss)
4
-6
1
0
2
0
-1
0
Interest Expense, net
0
0
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
2
1
1
1
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
2
-7
1
0
1
0
-1
0
Pretax Income (Loss), Adjusted
79
10
18
17
21
19
22
24
Abnormal Gains (Losses)
-18
4
-2
1
-2
0
-2
-7
Acquired In-Process R&D
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
Pretax Income (Loss)
61
14
17
17
19
19
19
17
Income Tax (Expense) Benefit, net
-22
-5
-6
-6
-6
-6
-6
-7
Current Income Tax
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
39
9
11
11
14
13
13
10
Net Extraordinary Gains (Losses)
0
-21
-29
0
1
0
0
0
Discontinued Operations
0
-21
-29
0
1
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
39
-12
-18
11
14
13
13
10
Minority Interest
0
0
0
0
0
0
0
0
Net Income
39
-12
-18
11
14
13
13
10
Preferred Dividends
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
39
-12
-18
11
14
13
13
10
Remarks
restated on Feb 14, 2012 n/a
calculated values,
restated on Dec 14, 2012 n/a
calculated values,
restated on Dec 11, 2013 n/a
calculated values,
restated on Dec 5, 2014 n/a
calculated values,
restated on Dec 4, 2015 n/a
calculated values,
restated on Dec 2, 2016 n/a
calculated values,
restated on Dec 2, 2016 n/a
calculated values,
restated on Dec 2, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
20
38
30
26
47
56
47
Cash & Cash Equivalents
n/a
11
23
16
15
44
56
25
Short Term Investments
n/a
9
15
14
10
3
0
22
Accounts & Notes Receivable
n/a
9
4
5
5
5
7
7
Accounts Receivable, Net
n/a
9
4
5
5
5
7
7
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
Inventories
n/a
3
3
4
3
3
3
4
Raw Materials
n/a
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
Other Short Term Assets
n/a
5
9
2
1
1
2
1
Prepaid Expenses
n/a
5
2
1
1
1
1
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
1
0
1
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
1
Discontinued Operations
n/a
0
6
1
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
0
Total Current Assets
n/a
37
55
40
36
55
68
59
Property, Plant & Equipment, Net
n/a
65
15
14
13
13
13
20
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
36
30
28
32
17
0
0
Long Term Investments
n/a
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
Other Long Term Assets
n/a
31
58
22
21
20
18
55
Intangible Assets
n/a
15
5
4
4
3
3
23
Goodwill
n/a
8
8
8
8
8
8
27
Other Intangible Assets
n/a
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
3
9
6
6
7
7
5
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
33
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
5
3
4
3
2
0
1
Total Noncurrent Assets
n/a
133
102
64
66
50
31
74
Total Assets
n/a
170
157
104
102
105
99
133
Liabilities and owners' equity
Payables & Accruals
n/a
5 5094000
3 2813000
3 2723000
2 2103000
2 1909000
2 1575000
4 3612000
Accounts Payable
n/a
3 3341000
2 1572000
2 1657000
1 954000
1 1028000
1 781000
2 1622000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
2 1753000
1 1241000
1 1066000
1 1149000
1 881000
1 794000
2 1990000
Short Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
3 2553000
8 8227000
4 4176000
4 3873000
2 2158000
3 3125000
7 6523000
Deferred Revenue
n/a
1 562000
0 53000
0 47000
0 43000
0 52000
0 48000
0 180000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
5 5349000
2 1640000
0 139000
0 45000
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
2 1991000
3 2825000
2 2489000
4 3691000
2 2061000
3 3077000
6 6343000
Total Current Liabilities
n/a
8 7647000
11 11040000
7 6899000
6 5976000
4 4067000
5 4700000
10 10135000
Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
8 8273000
6 6134000
2 2432000
2 2130000
2 2071000
2 2137000
16 15926000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
4 3598000
0 222000
0 185000
0 160000
0 226000
0 217000
0 188000
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
3 3491000
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
5 4675000
2 2421000
2 2247000
2 1970000
2 1845000
2 1920000
16 15738000
Total Noncurrent Liabilities
n/a
8 8273000
6 6134000
2 2432000
2 2130000
2 2071000
2 2137000
16 15926000
Total Liabilities
n/a
16 15920000
17 17174000
9 9331000
8 8106000
6 6138000
7 6837000
26 26061000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
71 70573000
75 75367000
19 19079000
3 2723000
3 3342000
4 3707000
7 7414000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
83 82900000
64 64394000
76 75869000
91 91036000
94 93881000
88 88161000
98 98146000
Other Equity
n/a
1 886000
0 -153000
0 40000
0 58000
2 1528000
0 5000
1 1273000
Equity Before Minority Interest
n/a
154 154359000
140 139608000
95 94988000
94 93817000
99 98751000
92 91873000
107 106833000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
154 154359000
140 139608000
95 94988000
94 93817000
99 98751000
92 91873000
107 106833000
Total Liabilities & Equity
n/a
170 170279000
157 156782000
104 104319000
102 101923000
105 104889000
99 98710000
133 132894000
Remarks restated on n/a restated on Feb 14, 2012 n/a restated on Dec 14, 2012 n/a restated on Dec 11, 2013 n/a restated on Dec 5, 2014 n/a restated on Dec 4, 2015 n/a restated on Dec 2, 2016 n/a restated on Dec 2, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
n/a
-21
-19
10
15
12
12
10
Net Income
n/a
0
0
0
0
0
0
0
Net Income From Discontinued Operations
n/a
0
0
0
0
0
0
0
Other Adjustments
n/a
0
0
0
0
0
0
0
Depreciation & Amortization
n/a
4
3
3
3
3
3
5
Non-Cash Items
n/a
35
32
2
1
3
3
5
Stock-Based Compensation
n/a
0
0
0
0
0
0
0
Deferred Income Taxes
n/a
0
0
0
0
0
0
0
Other Non-Cash Adjustments
n/a
0
0
0
0
0
0
0
Change in Working Capital
n/a
5
7
2
-1
1
-3
5
(Increase) Decrease in Accounts Receivable
n/a
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
n/a
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
n/a
0
0
0
0
0
0
0
Increase (Decrease) in Other
n/a
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
n/a
0
0
0
0
0
0
0
Cash from Operating Activities
n/a
22
23
18
18
19
15
25
Change in Fixed Assets & Intangibles
n/a
-3
-2
-1
-2
-2
-2
-8
Disposition of Fixed Assets & Intangibles
n/a
0
0
0
0
0
0
0
Disposition of Fixed Assets
n/a
0
0
0
0
0
0
0
Disposition of Intangible Assets
n/a
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
n/a
0
0
0
0
0
0
0
Purchase of Fixed Assets
n/a
0
0
0
0
0
0
0
Acquisition of Intangible Assets
n/a
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
n/a
0
0
0
0
0
0
0
Net Change in Long Term Investment
n/a
-11
-1
0
0
24
19
-22
Decrease in Long Term Investment
n/a
0
0
0
0
0
0
0
Increase in Long Term Investment
n/a
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
n/a
-1
-6
0
0
0
0
-26
Net Cash from Divestitures
n/a
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
n/a
0
0
0
0
0
0
0
Cash for Joint Ventures
n/a
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
n/a
0
0
0
0
0
0
0
Other Investing Activities
n/a
-6
-4
31
2
0
0
1
Net Cash From Discontinued Operations (investing)
n/a
0
0
0
0
0
0
0
Cash from Investing Activities
n/a
-21
-12
30
0
22
17
-55
Dividends Paid
n/a
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
n/a
0
0
0
0
0
0
0
Cash From (Repayment of) Short Term Debt, net
n/a
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
n/a
0
0
0
0
0
0
0
Repayments of Long Term Debt
n/a
0
0
0
0
0
0
0
Cash From Long Term Debt
n/a
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
n/a
-1
1
-55
-17
-12
-19
0
Increase in Capital Stock
n/a
1
1
0
0
1
1
0
Decrease in Capital Stock
n/a
-2
0
-55
-18
-13
-20
0
Other Financing Activities
n/a
-1
0
0
-1
-1
0
-1
Net Cash From Discontinued Operations (financing)
n/a
0
0
0
0
0
0
0
Cash from Financing Activities
n/a
-2
1
-55
-18
-13
-20
0
Net Cash Before Disc. Operations and FX
n/a
0
12
-8
0
28
12
-31
Change in Cash from Disc. Operations and Other
n/a
0
0
0
0
0
0
0
Net Cash Before FX
n/a
0
12
-8
0
28
12
-31
Effect of Foreign Exchange Rates
n/a
0
0
0
0
0
0
0
Net Changes in Cash
n/a
0
12
-8
0
28
12
-31
Remarks
restated on n/a
calculated values,
restated on Dec 14, 2012 n/a
calculated values,
restated on Dec 11, 2013 n/a
calculated values,
restated on Dec 5, 2014 n/a
calculated values,
restated on Dec 4, 2015 n/a
calculated values,
restated on Dec 2, 2016 n/a
calculated values,
restated on Dec 2, 2016 n/a
calculated values,
restated on Dec 2, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo